Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DRGZ61
|
|||
| Drug Name |
S-648414
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62] | Phase 1 | [1] | |
| Company |
Shionogi
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04147715) Evaluation of Safety, Tolerability, Pharmacokinetics, Drug-Drug and Food Interactions of Single and Multiple Doses of S-648414 in Healthy Adults. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.